Assessing the effectiveness of the expanded hepatitis A vaccination program in China: an interrupted time series design.

Our finding provides comprehensive evidence on the effectiveness of EHAP in China, particularly in the central and western regions, and among the population aged 0-24 years old. This study has important implications for the adjustment of vaccination strategies for other regions and populations.